Skip to main content
. 2018 Apr 25;8(2):312–319. doi: 10.1016/j.ijpddr.2018.04.006

Fig. 1.

Fig. 1

skn-1 mutations alter albendazole efficacy. (A) Percent long-term spontaneous motility of adult wild type N2 and skn-1(k1023gf) (gf, gain-of-function) worms exposed to 11 μM albendazole for 3 days. (B) Percent long-term spontaneous motility of adult wild type N2 and skn-1(zj15lf) (lf, loss-of-function) worms exposed to 2.5 μM albendazole for 3 days. (A and B) n > 150 worms per strain. ***P < 0.001 by Chi-square analysis. (C) Wild type N2 and skn-1(k1023gf) worms after 3 days on albendazole 11 μM plates.